Editas Medicine Inc. appointed Andrew Hirsch to its board.
Hirsch, CFO of Agios Pharmaceuticals, will also serve as chairman of the Editas board's audit committee.
Discover more about S&P Global’s offerings
Agios Pharmaceuticals CFO joins Editas Medicine board
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Editas Medicine Inc. appointed Andrew Hirsch to its board.
Hirsch, CFO of Agios Pharmaceuticals, will also serve as chairman of the Editas board's audit committee.